AU1760799A - A gel-form pharmaceutical preparation - Google Patents

A gel-form pharmaceutical preparation

Info

Publication number
AU1760799A
AU1760799A AU17607/99A AU1760799A AU1760799A AU 1760799 A AU1760799 A AU 1760799A AU 17607/99 A AU17607/99 A AU 17607/99A AU 1760799 A AU1760799 A AU 1760799A AU 1760799 A AU1760799 A AU 1760799A
Authority
AU
Australia
Prior art keywords
gel
pharmaceutical preparation
form pharmaceutical
preparation
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU17607/99A
Inventor
Kirsi Katila
Veli-Matti Lehtola
Pertti Rantala
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Oy
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras Oy filed Critical Leiras Oy
Publication of AU1760799A publication Critical patent/AU1760799A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
AU17607/99A 1997-12-23 1998-12-21 A gel-form pharmaceutical preparation Abandoned AU1760799A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI974610 1997-12-23
FI974610A FI974610A0 (en) 1997-12-23 1997-12-23 Pharmaceutical preparations in gelform
PCT/FI1998/001000 WO1999033471A1 (en) 1997-12-23 1998-12-21 A gel-form pharmaceutical preparation

Publications (1)

Publication Number Publication Date
AU1760799A true AU1760799A (en) 1999-07-19

Family

ID=8550206

Family Applications (1)

Application Number Title Priority Date Filing Date
AU17607/99A Abandoned AU1760799A (en) 1997-12-23 1998-12-21 A gel-form pharmaceutical preparation

Country Status (5)

Country Link
EP (1) EP1047430A1 (en)
AU (1) AU1760799A (en)
DK (1) DK200200342U3 (en)
FI (1) FI974610A0 (en)
WO (1) WO1999033471A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060018852A1 (en) 2003-08-22 2006-01-26 L'oreal Compositions containing topical active agents and pentylene glycol
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
CA2609579C (en) 2005-05-27 2014-08-19 Taro Pharmaceuticals North America, Inc. Stable liquid desoximetasone compositions with reduced oxidized impurity

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3899580A (en) * 1972-06-30 1975-08-12 Merck & Co Inc Anti-inflammatory topical gel
US4267173A (en) * 1979-11-05 1981-05-12 Schering Corporation Use of 6β-fluoro-7α-halogenocorticoids as topical anti-inflammatories and pharmaceutical formulations useful therefor
JPS59501159A (en) * 1982-06-24 1984-07-05 スミス、ロバ−ト・アラン medicated gel composition
US4775529A (en) * 1987-05-21 1988-10-04 Schering Corporation Steroid lotion
US5110809A (en) * 1988-03-21 1992-05-05 Bristol-Myers Squibb Company Antifungal gel formulations
US4866050A (en) * 1988-04-27 1989-09-12 Ben Amoz Daniel Ultrasonic transdermal application of steroid compositions

Also Published As

Publication number Publication date
WO1999033471A1 (en) 1999-07-08
EP1047430A1 (en) 2000-11-02
DK200200342U3 (en) 2003-02-28
FI974610A0 (en) 1997-12-23

Similar Documents

Publication Publication Date Title
ZA965368B (en) A pharmaceutical formulation
AU9187598A (en) Oral preparation
AU5387898A (en) Pharmaceutical agents
ZA96124B (en) A pharmaceutical formulation
EP1273300A3 (en) A stable external preparation containing aspirin
AU8591898A (en) Pharmaceutical compounds
GB9604736D0 (en) A pharmaceutical preparation
ZA982073B (en) Pharmaceutical preparation
AU4001297A (en) Capsule
AU9736998A (en) A noisescreen
AU1808897A (en) A calcitonin preparation
AU1760799A (en) A gel-form pharmaceutical preparation
ZA964372B (en) A pharmaceutical formulation
ZA965367B (en) A pharmaceutical formulation
GB2330773B (en) A skin-moisturising preparation
AU6596398A (en) Amusement ride - Case A
AUPO684497A0 (en) A game
ZA96122B (en) A pharmaceutical formulation
AU4920797A (en) A square
AU6355696A (en) Pharmaceutical preparation containing cyclosporin A
AU690505B3 (en) A pre-knotted knecktie
AU6387998A (en) Medicinal temporizer
AUPP640998A0 (en) A pharmaceutical formulation
GB9724175D0 (en) A pharmaceutical formulation
AU6425498A (en) New anticonvulsant drugs

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase